Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) - a Multi-centre Assessor-blind Randomised-controlled Trial

NCT05735639 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05735639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05735639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) - a Multi-centre Assessor-blind Randomised-controlled Trial
Lead sponsor
Imperial College London
Phase
Phase 4
Overall status
Recruiting
Start date
January 22, 2024
Completion date
December 31, 2027
Enrollment
3,175 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

varicose veins, venous thromboembolism